Isotonitazene has been identified in eight blood specimens associated with postmortem death investigations in the United States since August 2019. Isotonitazene was first reported in August 2019 based on the results from seized drug and toxicology casework in Europe (Belgium) and Canada (Alberta); the Canadian toxicology case was collected in March 2019.
(Publisher abstract provided.)
Similar Publications
- Fidelity in Implementing School-Based Restorative Justice Conferences
- Supporting students on school buses: Results from a nationally representative sample of head transportation officials
- The Lichtenberg Financial Decision Screening Scale (LFDSS): A new tool for assessing financial decision making and preventing financial exploitation